CBLB and malignant colon neoplasm: Further studies are needed to investigate whether TGFβ/Smad3 regulates Cbl-b expression and/or activity in colon cancer cells and whether Cbl-b is responsible for suppression of IRS-1 expression by TGFβ/Smad3 signaling.